Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1218-1227

  Zamora Ros, Raul ^a   Rinaldi, Sabina ^a   Biessy, Carine ^a   Tjønneland, Anne ^b   Halkjær, Jytte ^b   Fournier, Agnes ^c,d   Boutron Ruault, Marie Christine ^c,d   Mesrine, Sylvie ^c,d   Tikk, Kaja ^e   Fortner, Reneé T ^e   Boeing, Heiner ^f   Förster, Jana ^f   Trichopoulou, Antonia ^g,h   Trichopoulos, Dimitrios ^g,h,i   Papatesta, Eleni Maria ^g   Masala, Giovanna ^j   Tagliabue, Giovanna ^k   Panico, Salvatore ^l   Tumino, Rosario ^m   Polidoro, Silvia ⁿ   Peeters, Petra H M ^o,p   Bueno De Mesquita, H Bas ^o,p,q   Weiderpass, Elisabete ^r,s,t,u   Lund, Eiliv ^r   Argüelles, Marcial ^v   Agudo, Antonio ^w   Molina Montes, Esther ^x,y   Navarro, Carmen ^y,z,aa   Barricarte, Aurelio ^y,ab   Larrañaga, Nerea ^y,ac   Manjer, Jonas ^ad   Almquist, Martin ^ad   Sandström, Maria ^ae   Hennings, Joakim ^ae   Tsilidis, Konstantinos K ^af,ag   Schmidt, Julie A ^af   Khaw, Kay Thee ^ah   Wareham, Nicholas J ^ai   Romieu, Isabelle ^a   Byrnes, Graham ^a   Gunter, Marc J ^p   Riboli, Elio ^p   Franceschi, Silvia ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^g HELLENIC HEALTH FOUNDATION   (Greece)

^h BIOMEDICAL RESEARCH FOUNDATION   (Greece)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m CIVILE M P AREZZO HOSPITAL   (Italy)

ⁿ Human Genetics Foundation   (Italy)

^o UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^p IMPERIAL COLLEGE LONDON   (United Kingdom)

^q NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^r UNIVERSITY OF TROMSØ   (Norway)

^s CANCER REGISTRY OF NORWAY   (Norway)

^t KAROLINSKA INSTITUTE   (Sweden)

^u FOLKHÄLSAN RESEARCH CENTER   (Finland)

^v Health Department of the Autonomous Government of Asturias   (Spain)

^w CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^x ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^y CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^z DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^aa UNIVERSITY OF MURCIA   (Spain)

^ab INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ac Public Health Division of Gipuzkoa   (Spain)

^ad LUND UNIVERSITY HOSPITAL   (Sweden)

^ae UMEÅ UNIVERSITY   (Sweden)

^af UNIVERSITY OF OXFORD   (United Kingdom)

^ag UNIVERSITY OF IOANNINA   (Greece)

^ah UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ai UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

Differentiated thyroid carcinoma; EPIC; Hormone use; Menstrual factors; Reproductive factors

Indexed keywords

ADULT; ARTICLE; BREAST FEEDING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; FEMALE INFERTILITY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENARCHE; MENOPAUSE; MENSTRUATION; MIDDLE AGED; ORAL CONTRACEPTIVE USE; PATHOGENESIS; PREGNANCY; PROSPECTIVE STUDY; REPRODUCTIVE HEALTH; RISK FACTOR; ADVERSE EFFECTS; CELL DIFFERENTIATION; ESTROGEN THERAPY; EUROPE; FOLLOW UP; INCIDENCE; LIFESTYLE; PATHOLOGY; PROGNOSIS; REPRODUCTIVE HISTORY; THYROID NEOPLASMS; YOUNG ADULT;

ORAL CONTRACEPTIVE AGENT;

ADULT; CELL DIFFERENTIATION; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE STYLE; MALE; MENOPAUSE; MENSTRUATION; MIDDLE AGED; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84918787441     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29067     Document Type: Article

References (32)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013.
2. Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009;20:525-31.
3. Rinaldi S, Lise M, Clavel-Chapelon F, et al. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 2012;131:E1004-E1014.
4. Zhao ZG, Guo XG, Ba CX, et al. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 2012;40:2041-50.
5. Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009;20:75-86.
6. Brindel P, Doyon F, Rachedi F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008;167:219-29.
7. La Vecchia C, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999;10:157-66.
8. Mack WJ, Preston-Martin S, Bernstein L, et al. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev 1999;8:991-7.
9. Memon A, Darif M, Al-Saleh K, et al. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer 2002;97:82-9.
10. Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10:143-55.
11. Rossing MA, Voigt LF, Wicklund KG, et al. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765-72.
12. Sakoda LC, Horn-Ross PL. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 2002;11:51-7.
13. Truong T, Orsi L, Dubourdieu D, et al. Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 2005;161:1056-65.
14. Zivaljevic V, Vlajinac H, Jankovic R, et al. Casecontrol study of female thyroid cancer-menstrual, reproductive and hormonal factors. Eur J Cancer Prev 2003;12:63-6.
15. Fernandez E, Gallus S, Bosetti C, et al. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 2003;105:408-12.
16. Akslen LA, Nilssen S, Kvale G. Reproductive factors and risk of thyroid cancer. A prospective study of 63, 090 women from Norway. Br J Cancer 1992;65:772-4.
17. Dorjgochoo T, Shu XO, Li HL, et al. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer 2009;124:2442-9.
18. Hannibal CG, Jensen A, Sharif H, et al. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 2008;23:451-6.
19. Horn-Ross PL, Canchola AJ, Ma H, et al. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev 2011;20:1751-9.
20. Meinhold CL, Ron E, Schonfeld SJ, et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 2010;171:242-52.
21. Navarro Silvera SA, Miller AB, Rohan TE. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer 2005;116:433-8.
22. Braganza MZ, De Gonzalez AB, Schonfeld SJ, et al. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev Res (Phila) 2014;7:418-25.
23. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
24. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-13.
25. De Groot LJ, Mestman J. Detecting and treating thyroid nodules and cancer before, during, and after pregnancy: a patient's guide. J Clin Endocrinol Metab 2012;97:37A-38A.
26. McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab 2012;97:2682-92.
27. Stefaneanu L, Tasca C. Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. Acta Histochem 1986;78:7-18.
28. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702-55.
29. Schonfeld SJ, Ron E, Kitahara CM, et al. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol 2011;35:e85-e90.
30. Rinaldi S, Plummer M, Biessy C, et al. Thyroidstimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst 2014;13: dju097.
31. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 2012;44:319-22.
32. Schonfeld SJ, Neta G, Sturgis EM, et al. Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid 2012;22:151-6.